© 2020 MJH Life Sciences and HCPLive. All rights reserved.
Pulmonology
Dupilumab Reduces Asthma Exacerbation Rates
August 08, 2020
Article
Dupilumab significantly reduces exacerbation rates in patients with asthma compared to standard of care.
GDC-0214 Well-Tolerated for Patients with Mild Asthma
August 08, 2020
Article
In a study presented virtually at ATS 2020, investigators find 15 mg of the study drug resulted in a 43% decrease in FeNO.
Autopsies, Biopsies Link Lung Injuries to E-Cigarette Use
August 07, 2020
Article
A new case study assesses biopsy and autopsy tissues to characterize pathological patterns in suspected EVALI cases .
Tezepelumab Helps Reduce Severe Asthma Exacerbations
August 07, 2020
Article
In a study presented at ATS 2020, investigators test 3 different dosing regimens of tezepelumab in asthma patients with both high and low levels of IL-5 and IL-13.
The 4 Mistakes Made by the US in COVID-19 Response
August 07, 2020
Article
A famed virologist weighs in on the country's earliest shortcomings—and how they can still be resolved today.
Nirsevimab Shows Promise in Preventing RSV Infections in Preterm-Born Infants
August 06, 2020
Article
A one-time intramuscular dose of the investigative drug was linked to reduced medical attention and hospitalizations related to RSV.
Older, Male Asthmatics at Greater COVID-19 Severity Risk
August 05, 2020
Article
New findings suggest differing chronic lung diseases are associated with varying risk factors among COVID-19 patients.
COVID-19 Complications & Searches for a Cure with Dr. David Ho
August 04, 2020
Podcast
World-leading virologist and AIDS researcher David Ho, MD, joins the inaugural podcast episode.
How VTE Screening Can Be Improved
July 31, 2020
Video
A discussion on how thromboembolism research and care could benefit from progression in diagnostics.
New Data Expands the Risk Pool for Mortality From Elevated Pulmonary Artery Pressure
July 30, 2020
Article
Patients with a mPAP of at least 19 mm Hg and pulmonary artery wedge pressure of 15 mm Hg or less had an adjusted hazard ratio for mortality of 1.71.